Literature DB >> 17408594

Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2.

Su-Ryun Kim1, Soo-Kyung Bae, Kyu-Sil Choi, Shi-Young Park, Hyung Oh Jun, Ju-Youn Lee, Hye-Ock Jang, Il Yun, Kwon-Ha Yoon, Yung-Jin Kim, Mi-Ae Yoo, Kyu-Won Kim, Moon-Kyoung Bae.   

Abstract

Adipose tissue is highly vascularized and requires the angiogenic properties for its mass growth. Visfatin has been recently characterized as a novel adipokine, which is preferentially produced by adipose tissue. In this study, we report that visfatin potently stimulates in vivo neovascularization in chick chorioallantoic membrane and mouse Matrigel plug. We also demonstrate that visfatin activates migration, invasion, and tube formation in human umbilical vein endothelial cells (HUVECs). Moreover, visfatin evokes activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) in endothelial cells, which is closely linked to angiogenesis. Inhibition of ERK activation markedly decreases visfatin-induced tube formation of HUVECs and visfatin-stimulated endothelial cell sprouting from rat aortic rings. Taken together, these results demonstrate that visfatin promotes angiogenesis via activation of mitogen-activated protein kinase ERK-dependent pathway and suggest that visfatin may play important roles in various pathophysiological angiogenesis including adipose tissue angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408594     DOI: 10.1016/j.bbrc.2007.03.105

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  Nicotinamide Phosphoribosyltransferase in Human Diseases.

Authors:  Li Qin Zhang; Daniel P Heruth; Shui Qing Ye
Journal:  J Bioanal Biomed       Date:  2011-01-07

2.  Relationship between serum visfatin levels and coronary slow-flow phenomenon.

Authors:  Huseyin Altug Cakmak; Serkan Aslan; Ahmet Arif Yalcin; Ibrahim Faruk Akturk; Burce Yalcin; Fatih Uzun; Derya Ozturk; Mehmet Erturk; Mehmet Gul
Journal:  Herz       Date:  2015-05-05       Impact factor: 1.443

3.  Mapping the extracellular and membrane proteome associated with the vasculature and the stroma in the embryo.

Authors:  Fabienne Soulet; Witold W Kilarski; Florence Roux-Dalvai; John M J Herbert; Izabela Sacewicz; Emmanuelle Mouton-Barbosa; Roy Bicknell; Patricia Lalor; Bernard Monsarrat; Andreas Bikfalvi
Journal:  Mol Cell Proteomics       Date:  2013-05-14       Impact factor: 5.911

Review 4.  The NAD metabolome--a key determinant of cancer cell biology.

Authors:  Alberto Chiarugi; Christian Dölle; Roberta Felici; Mathias Ziegler
Journal:  Nat Rev Cancer       Date:  2012-09-28       Impact factor: 60.716

Review 5.  The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia.

Authors:  Xinzhi Chen; Shangfeng Zhao; Yang Song; Yejie Shi; Rehana K Leak; Guodong Cao
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

6.  Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group.

Authors:  Kui Zhang; Bin Zhou; Peng Zhang; Zhu Zhang; Peng Chen; Yan Pu; Yaping Song; Lin Zhang
Journal:  Tumour Biol       Date:  2013-12-22

7.  Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFkB-dependent manner.

Authors:  Radu C Oita; Dudley Ferdinando; Steve Wilson; Christopher Bunce; Dawn J Mazzatti
Journal:  Pflugers Arch       Date:  2009-11-08       Impact factor: 3.657

Review 8.  Nampt: linking NAD biology, metabolism and cancer.

Authors:  Antje Garten; Stefanie Petzold; Antje Körner; Shin-Ichiro Imai; Wieland Kiess
Journal:  Trends Endocrinol Metab       Date:  2008-12-26       Impact factor: 12.015

Review 9.  Physiological and pathophysiological roles of NAMPT and NAD metabolism.

Authors:  Antje Garten; Susanne Schuster; Melanie Penke; Theresa Gorski; Tommaso de Giorgis; Wieland Kiess
Journal:  Nat Rev Endocrinol       Date:  2015-07-28       Impact factor: 43.330

10.  The novel adipocytokine visfatin exerts direct cardioprotective effects.

Authors:  Shiang Y Lim; Sean M Davidson; Ajeev J Paramanathan; Christopher C T Smith; Derek M Yellon; Derek J Hausenloy
Journal:  J Cell Mol Med       Date:  2008-04-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.